Page last updated: 2024-11-05

triamterene and Burkitt Lymphoma

triamterene has been researched along with Burkitt Lymphoma in 1 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schalhorn, A1
Siegert, W1
Sauer, HJ1

Other Studies

1 other study available for triamterene and Burkitt Lymphoma

ArticleYear
Antifolate effect of triamterene on human leucocytes and on a human lymphoma cell line.
    European journal of clinical pharmacology, 1981, Volume: 20, Issue:3

    Topics: Burkitt Lymphoma; Cell Line; DNA, Neoplasm; Folic Acid Antagonists; Humans; Leukemia; Leukocytes; Te

1981